Application 213951
- Type
- ANDA
- Sponsor
- VISTAPHARM
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | ACYCLOVIR | ACYCLOVIR | SUSPENSION;ORAL | 200MG/5ML | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A213951-001 | ACYCLOVIR | ACYCLOVIR | 200MG/5ML | SUSPENSION / ORAL | 2021-01-11 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A213951-001 | ACYCLOVIR | 200MG/5ML | SUSPENSION / ORAL | 2021-01-11 | 84e616aacf4f… | ||
| 2026-08-18 06:07:40 | 2026-07 | A213951-001 | ACYCLOVIR | 200MG/5ML | SUSPENSION / ORAL | 2021-01-11 | caaa826d4ba7… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A213951-001 | ACYCLOVIR | 200MG/5ML | SUSPENSION / ORAL | 2021-01-11 | 011fe1cb6892… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A213951-001 | ACYCLOVIR | 200MG/5ML | SUSPENSION / ORAL | 2021-01-11 | 31067a03dcf5… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A213951-001 | ACYCLOVIR | 200MG/5ML | SUSPENSION / ORAL | 2021-01-11 | 6a471c1ec25d… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A213951-001 | ACYCLOVIR | 200MG/5ML | SUSPENSION / ORAL | 2021-01-11 | fd3edfee7708… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A213951-001 | ACYCLOVIR | 200MG/5ML | SUSPENSION / ORAL | 2021-01-11 | b8a1b40f171c… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A213951-001 | ACYCLOVIR | 200MG/5ML | SUSPENSION / ORAL | 2021-01-11 | 03ed91905a0d… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A213951-001 | ACYCLOVIR | 200MG/5ML | SUSPENSION / ORAL | 2021-01-11 | 2680178bc6a6… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A213951-001 | ACYCLOVIR | 200MG/5ML | SUSPENSION / ORAL | 2021-01-11 | 5bbf6a4d5a75… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A213951-001 | ACYCLOVIR | 200MG/5ML | SUSPENSION / ORAL | 2021-01-11 | d8e5a09893c0… | ||
| 2024-10-29 15:01 UTC | 2024-10 | A213951-001 | ACYCLOVIR | 200MG/5ML | SUSPENSION / ORAL | 2021-01-11 | d06236e962d9… | ||
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A213951-001 | ACYCLOVIR | 200MG/5ML | SUSPENSION / ORAL | 2021-01-11 | 79d66fd596c7… | ||
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A213951-001 | ACYCLOVIR | 200MG/5ML | SUSPENSION / ORAL | 2021-01-11 | 301d65b070ca… | ||
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A213951-001 | ACYCLOVIR | 200MG/5ML | SUSPENSION / ORAL | 2021-01-11 | 1e350fbaab3a… | ||
| 2024-05-31 18:47 UTC | 2024-05 | A213951-001 | ACYCLOVIR | 200MG/5ML | SUSPENSION / ORAL | 2021-01-11 | 8072bd15b7f6… | ||
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A213951-001 | ACYCLOVIR | 200MG/5ML | SUSPENSION / ORAL | AB | 2021-01-11 | 5c6f7cd8ea54… | |
| 2022-04-08 23:34 UTC | 2022-04 | A213951-001 | ACYCLOVIR | 200MG/5ML | SUSPENSION / ORAL | AB | 2021-01-11 | 5d02ea3f76ae… | |
| 2022-04-04 05:41 UTC | 2022-04 | A213951-001 | ACYCLOVIR | 200MG/5ML | SUSPENSION / ORAL | AB | 2021-01-11 | 4b0b4de00fa7… | |
| 2022-03-09 01:35 UTC | 2022-03 | A213951-001 | ACYCLOVIR | 200MG/5ML | SUSPENSION / ORAL | AB | 2021-01-11 | bb7c543d1eb4… | |
| 2021-12-28 21:50 UTC | 2021-12 | A213951-001 | ACYCLOVIR | 200MG/5ML | SUSPENSION / ORAL | AB | 2021-01-11 | 782e0a99824c… | |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | A213951-001 | ACYCLOVIR | 200MG/5ML | SUSPENSION / ORAL | AB | 2021-01-11 | 87673890dc5c… | |
| 2021-03-12 10:30 UTC | 2021-03 | A213951-001 | ACYCLOVIR | 200MG/5ML | SUSPENSION / ORAL | AB | 2021-01-11 | 5aa47cf7b7d7… | |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A213951-001 | ACYCLOVIR | 200MG/5ML | SUSPENSION / ORAL | 2021-01-11 | 6a51e52b5d6a… | ||
| 2024-02-18 07:12 UTC | 2024-02 | A213951-001 | ACYCLOVIR | 200MG/5ML | SUSPENSION / ORAL | 2021-01-11 | 1c564ffb4f44… | ||
| 2023-12-20 04:57 UTC | 2023-12 | A213951-001 | ACYCLOVIR | 200MG/5ML | SUSPENSION / ORAL | 2021-01-11 | ea1830bbd6c7… | ||
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | A213951-001 | ACYCLOVIR | 200MG/5ML | SUSPENSION / ORAL | 2021-01-11 | a72a2bbeb626… | ||
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | A213951-001 | ACYCLOVIR | 200MG/5ML | SUSPENSION / ORAL | AB | 2021-01-11 | 9b2671bbb829… | |
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | A213951-001 | ACYCLOVIR | 200MG/5ML | SUSPENSION / ORAL | AB | 2021-01-11 | a67488948f0b… | |
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | A213951-001 | ACYCLOVIR | 200MG/5ML | SUSPENSION / ORAL | AB | 2021-01-11 | 3f0d92c62455… | |
| 2023-05-13 08:27 UTC | 2023-05 | A213951-001 | ACYCLOVIR | 200MG/5ML | SUSPENSION / ORAL | AB | 2021-01-11 | 053a50430f4f… | |
| 2023-01-26 05:58 UTC | 2023-01 | A213951-001 | ACYCLOVIR | 200MG/5ML | SUSPENSION / ORAL | AB | 2021-01-11 | 3bdfa0b2c4d7… | |
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | A213951-001 | ACYCLOVIR | 200MG/5ML | SUSPENSION / ORAL | AB | 2021-01-11 | 3a93d1ddd44b… | |
| 2022-10-28 04:53 UTC | 2022-10 | A213951-001 | ACYCLOVIR | 200MG/5ML | SUSPENSION / ORAL | AB | 2021-01-11 | f41ea6bd6efb… | |
| 2022-09-29 23:25 UTC | 2022-09 | A213951-001 | ACYCLOVIR | 200MG/5ML | SUSPENSION / ORAL | AB | 2021-01-11 | e64feba35796… | |
| 2022-07-09 03:26 UTC · 3 captures of this ZIP | 2022-07 | A213951-001 | ACYCLOVIR | 200MG/5ML | SUSPENSION / ORAL | AB | 2021-01-11 | cb3db0bc1861… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A213951-001 | ACYCLOVIR | 200MG/5ML | SUSPENSION / ORAL | 2021-01-11 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A213951-001 | AB | 1 | 5c6f7cd8ea54… |
| 2022-04-08 23:34 UTC | 2022-04 | A213951-001 | AB | 1 | 5d02ea3f76ae… |
| 2022-04-04 05:41 UTC | 2022-04 | A213951-001 | AB | 1 | 4b0b4de00fa7… |
| 2022-03-09 01:35 UTC | 2022-03 | A213951-001 | AB | 1 | bb7c543d1eb4… |
| 2021-12-28 21:50 UTC | 2021-12 | A213951-001 | AB | 1 | 782e0a99824c… |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | A213951-001 | AB | 1 | 87673890dc5c… |
| 2021-03-12 10:30 UTC | 2021-03 | A213951-001 | AB | 1 | 5aa47cf7b7d7… |
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | A213951-001 | AB | 1 | 9b2671bbb829… |
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | A213951-001 | AB | 1 | a67488948f0b… |
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | A213951-001 | AB | 1 | 3f0d92c62455… |
| 2023-05-13 08:27 UTC | 2023-05 | A213951-001 | AB | 1 | 053a50430f4f… |
| 2023-01-26 05:58 UTC | 2023-01 | A213951-001 | AB | 1 | 3bdfa0b2c4d7… |
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | A213951-001 | AB | 1 | 3a93d1ddd44b… |
| 2022-10-28 04:53 UTC | 2022-10 | A213951-001 | AB | 1 | f41ea6bd6efb… |
| 2022-09-29 23:25 UTC | 2022-09 | A213951-001 | AB | 1 | e64feba35796… |
| 2022-07-09 03:26 UTC · 3 captures of this ZIP | 2022-07 | A213951-001 | AB | 1 | cb3db0bc1861… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Acyclovir | ACYCLOVIR | NuCare Pharmaceuticals,Inc. | b455053f-3deb-bd76-e053-2a95a90a9869 | 2024-07-17 | Warnings, Adverse reactions | Acyclovir ACYCLOVIR |
| Acyclovir | ACYCLOVIR | NuCare Pharmaceuticals,Inc. | 638803d2-a172-486d-e053-2991aa0ab074 | 2024-07-16 | Warnings, Adverse reactions | Acyclovir ACYCLOVIR |
| Acyclovir | ACYCLOVIR | Fresenius Kabi USA, LLC | badf347b-eeee-4239-9c74-966f262925aa | 2024-06-30 | Warnings, Adverse reactions | Acyclovir ACYCLOVIR |
| Acyclovir | ACYCLOVIR | Fresenius Kabi USA, LLC | cb64dfab-52ee-4312-bc9c-c3d04efe9109 | 2024-06-27 | Warnings, Adverse reactions | Acyclovir ACYCLOVIR |
| acyclovir | ACYCLOVIR | NuCare Pharmaceuticals,Inc. | 968800dc-9456-a45f-e053-2995a90aa15e | 2024-06-19 | Warnings, Adverse reactions | acyclovir ACYCLOVIR |
| Acyclovir | ACYCLOVIR | Bryant Ranch Prepack | 67a7ab8b-4b85-4f7b-8ae0-3dcdc273ed69 | 2024-06-18 | Warnings, Adverse reactions | Acyclovir ACYCLOVIR |
| Acyclovir | ACYCLOVIR | NuCare Pharmaceuticals,Inc. | 83e82707-85b6-2fea-e053-2991aa0a99ef | 2024-06-14 | Warnings, Adverse reactions | Acyclovir ACYCLOVIR |
| acyclovir | ACYCLOVIR | Bryant Ranch Prepack | bf1b4142-c5f3-4147-8224-bf6344566694 | 2024-05-30 | Warnings, Adverse reactions | acyclovir ACYCLOVIR |
| ACYCLOVIR | ACYCLOVIR | Bryant Ranch Prepack | 331fe0bd-6bb2-4337-8faa-d0c82ff54dc7 | 2024-05-24 | Warnings, Adverse reactions | ACYCLOVIR ACYCLOVIR |
| Acyclovir | ACYCLOVIR | Hikma Pharmaceuticals USA Inc. | babdbce2-5cbd-4943-bc38-9ebdd696a77a | 2024-04-11 | Warnings, Adverse reactions | Acyclovir ACYCLOVIR |
| ACYCLOVIR | ACYCLOVIR | Bryant Ranch Prepack | c0e41bf9-e141-404e-9952-aeeb705958b4 | 2024-04-05 | Warnings, Adverse reactions | ACYCLOVIR ACYCLOVIR |
| Acyclovir | ACYCLOVIR | Bryant Ranch Prepack | e73ae5c8-7a77-4330-817d-482d1de4e994 | 2024-04-05 | Warnings, Adverse reactions | Acyclovir ACYCLOVIR |
| Acyclovir | ACYCLOVIR | Padagis Israel Pharmaceuticals Ltd | 63fadf54-e8a3-4512-8a05-d64b998f5a08 | 2024-03-31 | Warnings, Adverse reactions | Acyclovir ACYCLOVIR |
| acyclovir | ACYCLOVIR | Slate Run Pharmaceuticals, LLC | 889bccd1-3793-40ce-bca2-c8c9cf6b7488 | 2024-02-29 | Warnings, Adverse reactions | acyclovir ACYCLOVIR |
| Acyclovir | ACYCLOVIR | A-S Medication Solutions | 6e813b35-4ead-42d6-bc51-9d7caf1db1ef | 2024-02-13 | Warnings, Adverse reactions | Acyclovir ACYCLOVIR |
| acyclovir | ACYCLOVIR | A-S Medication Solutions | f3e6b1ad-810b-4f53-b92a-b28fc2111f3f | 2024-01-25 | Warnings, Adverse reactions | acyclovir ACYCLOVIR |
| Acyclovir | ACYCLOVIR | Bryant Ranch Prepack | a4c15f29-313f-49ca-acfa-c0e6910f64fb | 2024-01-25 | Warnings, Adverse reactions | Acyclovir ACYCLOVIR |
| Acyclovir | ACYCLOVIR | Bryant Ranch Prepack | e2b2c88a-84d2-42e6-ad18-819f7e78dbd6 | 2024-01-10 | Warnings, Adverse reactions | Acyclovir ACYCLOVIR |
| Acyclovir | ACYCLOVIR | Bryant Ranch Prepack | d04c696f-c072-46f7-9a92-9cbb476c827b | 2024-01-10 | Warnings, Adverse reactions | Acyclovir ACYCLOVIR |
| Acyclovir | ACYCLOVIR | Proficient Rx LP | 97ed8713-4b3e-48a9-92c0-0a98ecf0485c | 2024-01-01 | Warnings, Adverse reactions | Acyclovir ACYCLOVIR |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.